Rationale and Purpose: The FLUTE Study to Evaluate Fluorography Mass Screening for Tuberculosis and Other Diseases, as Conducted in Eastern Europe and Central Asia Countries

Vitaly Smelov, Olga Trusova, Sylvaine Barbier, Richard Muwonge, Viatcheslav Grankov, Valiantsin Rusovich, Armando Baena, Mary Lyn Gaffield, Marilys Anne Corbex and Masoud Dara
Additional contact information
Vitaly Smelov: World Health Organization (WHO) Regional Office for Europe, 2100 Copenhagen, Denmark
Olga Trusova: Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer (IARC) WHO, 69372 Lyon, France
Sylvaine Barbier: Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer (IARC) WHO, 69372 Lyon, France
Richard Muwonge: Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer (IARC) WHO, 69372 Lyon, France
Viatcheslav Grankov: World Health Organization (WHO) Country Office, 220007 Minsk, Belarus
Valiantsin Rusovich: World Health Organization (WHO) Country Office, 220007 Minsk, Belarus
Armando Baena: Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer (IARC) WHO, 69372 Lyon, France
Mary Lyn Gaffield: World Health Organization (WHO) Headquarters, 1211 Geneva, Switzerland
Marilys Anne Corbex: World Health Organization (WHO) Regional Office for Europe, 2100 Copenhagen, Denmark
Masoud Dara: World Health Organization (WHO) Country Office, 220007 Minsk, Belarus

IJERPH, 2022, vol. 19, issue 14, 1-16

Abstract: In Belarus and several EECA countries, periodic population-based chest X-ray “fluorography programme” use as a mass screening tool for the diagnosis of tuberculosis (TB) has been used for decades. This mass screening has also often been justified for the early detection of lung cancer (LC), although no mortality benefits were demonstrated by screening with chest X-ray in international randomized trials. In Belarus, fluorography testing is mandatory every one to three years for all adults depending on age and the so-called “risk groups”. The World Bank and WHO estimate that Belarus spends USD11 million annually on mass fluorography screening and advocate for more targeted screening approaches to increase diagnostic yield for TB and not to use it for screening for LC. The study is a retrospective review of medical records to assess the yield of fluorography to detect true cases of LC and/or TB in asymptomatic patients in two rural and two urban districts in Belarus for 2015–2017 with positive screening results for presumed of TB or LC. The study provided the rationale to implement the improved policy and practices regarding the role of fluorography in the early detection of LC and TB in Belarus and elsewhere.

Keywords: lung cancer; pulmonary tuberculosis; fluorography; chest X-ray; dispanserization; Belarus; screening (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/14/8706/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/14/8706/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:14:p:8706-:d:864835

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().